A Sheep in Wolf's Clothing

Hepatology

Volumn 38, Issue 6, 2003, Pages 1596-1601

  Reuben, Adrian ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; STEROID;

AUTOIMMUNE HEPATITIS; HISTORY OF MEDICINE; HUMAN; LUPOID HEPATITIS; LUPUS ERYTHEMATOSUS; PRIORITY JOURNAL; PUBLICATION; REVIEW; WALDENSTROEM MACROGLOBULINEMIA;

EID: 0345017708     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510380643     Document Type: Review

References (69)

1. Daly L. Æsop without morals. New York: Thomas Yoseloff, 1961.
2. Herodotus, with an English translation by AD Godley. Cambridge: Harvard University Press, 1920. 2.134.1
3. Joron M, Mallet J. Diversity in mimicry: paradox or paradigm? Trends Ecol Evolution 1998:13;461-466.
4. Miller OS, Finck FM. Malacoplakia of the kidney: the great impersonator. J Urol 1970;103:712-717.
5. Heffernon EW. The irritable colon - the great impersonator. Am J Gastroenterol 1965;43:468-471.
6. Gay HH. Mimae - the great impersonator. J Mich State Med Soc 1963;62:976.
7. Mallory FB. Cirrhosis of the liver. N Engl J Med 1932;206:1231-1239.
8. Barker MH, Capps RB, Allen FW. Chronic hepatitis in the Mediterranean theater: a new clinical syndrome. J Am Med Assoc 1945;129:653-659.
9. Capps RB. Clinical aspects of the sequelae of acute hepatitis. Gastroenterology 1948;11:680-684.
10. Palmer WL. Acute and chronic hepatitis (cirrhosis). Ill Med J 1944;85:143-147.
11. Alstead G. Studies on malignant hepatitis. Am J Med Sci 1947;213:257-267.
12. Iversen AP. Om hepatitis: aetiologi og epidemiologi. Nord Med (Hospitalstid) 1946;30:733-743.
13. Neefe JR, Gambesca JM, Kurtz CH, Smith MD, Beebe AW, Jablon S, Reinhold JG, et al. Prevalence and nature of hepatic disturbance following acute viral hepatitis with jaundice. Ann Intern Med 1955;43:1-32.
14. Zieve L, Hill E, Nesbitt S, Zieve B. The incidence of residuals of viral hepatitis. Gastroenterology 1953;25:495-531.
15. Caravati CM. Post-hepatitis syndrome. South Med J 1944;37:251-257.
16. Cullinan ER. Idiopathic jaundice (often recurrent) associated with subacute necrosis of the liver. St. Bartholomew's Hosp Rep 1936;69:55-142.
17. Amberg S. Hyperproteinemia associated with severe liver disease. Proc Staff Meet Mayo Clin 1942;17:360-362.
18. Jersild M. Stigende hyppighead at hepatitis chronica. Ugeskrift for Laeger 1945;107:819.
19. Himsworth HP. Lectures on the liver and its diseases, comprising the Lowell Lectures delivered at Boston Massachusetts in March 1947, pages 159-160. Oxford: Blackwell Scientific Publications.
20. Wood IJ, King WE, Parson PJ, Perry JW, Freeman M, Limbrick L. Non-suppurative hepatitis: a study of acute and chronic forms with special reference to biochemical and histological changes. Med J Aust 1948;11:249-261.
21. Klatskin G. Subacute necrosis and postnecrotic cirrhosis due to anicteric infections with the hepatitis virus. Am J Med 1958;25:333-358.
22. Waldenström J. Leber, Blutproteine und Nahrungseiweiß. Dtsch Z Verdau Staffwechselkr 1950;15:113-119.
23. Kunkel HG, Ahrens EH Jr, Eigenmenger WJ, Bongiovanni AM, Slater RJ. Extreme hypergammaglobulinemia in young women with liver disease of unknown etiology [abstract]. J Clin Invest 1951;30:654.
24. Kyle RA, Anderson KC. A tribute to Jan Gösta Waldenström. Blood 1997;89:4245-4247.
25. Waldenström J. Studien über porphyrie. Acta Med Scan 1937;(suppl 82):3.
26. Waldenström J. Studies on conditions associated with disturbed gammaglobulin formation (Gammopathies). Harvey Lect 1961;56:211.
27. Capra JD, Tan EM, eds. Biography of Henry G. Kunkel and the Founding of the Henry Kunkel Society. New York: The Henry Kunkel Society, 2001.
28. Bearn AG, Kunkel HG, Slater RJ. The problem of liver disease in young women. Am J Med 1956;21:3-15.
29. Saint EG, King WE, Joske RA, Finch ES. The course of infectious hepatitis with special reference to prognosis and the chronic stage. Aust Ann Med 1953;2:113-127.
30. De Groote J, Desmet VJ, Gedigk P, Korb G, Popper H, Poulsen H, Scheuer P, et al. A classification of chronic hepatitis. Lancet 1968;2:626-628.
31. Desmet VJ. Chronic hepatitis (including primary biliary cirrhosis). In: Gall EA, Mostaff FK, eds. The Liver by 34 Authors. Baltimore: Williams and Wilkins 1973;286-341.
32. Mackay IR, Weiden S, Hasker J. Autoimmune hepatitis. Ann N Y Acad Sci 1965;124:767-780.
33. Meyer zum Buschenfelde K-H, Gerken G. Immune mechanisms in the production of liver diseases. In: Zakim D, Boyer T, eds. Hepatology - A Textbook of Liver Disease. 4th Edition. Philadelphia: Saunders, 2002.
34. Strassburg CP, Manns MP. Autoantibodies and autoantigens in autoimmune hepatitis. Semin Liver Dis 2002;22:339-351.
35. McFarlane IG, Vergani D, Eddleston LWF. Chapter 3 - Pathogenesis of autoimmune hepatitis. In: Krawitt EL, Wiesner RH, Nishioka M, eds. Autoimmune Liver Disease. 2nd Edition. Amsterdam: Elsevier Science BV, 1998.
36. Zimmerman HJ, Heller P, Hill RP. Extreme hyperglobulinemia in subacute hepatic necrosis. N Engl J Med 1951;244:245-259.
37. Mackay IR. Chronic active hepatitis. Front Gastrointest Res 1974;1:142-187.
38. Takata M, Ara K. Ober eine neue Kolloidchemische liquorreaktion und ihre praktischen ergebnisse. 1925 Trans 6th Congr Far Eastern Assoc Trop Med. Tokyo 1:667.
39. Hanger FM. Serological differentiation of obstructive from hepatogenous jaundice by flocculation of cephalin-cholesterol emulsions. J Clin Invest 1939;18:261-269.
40. Maclagen NF. The thymol turbidity as an indicator of liver dysfunction. Brit J Exp Pathol 1944;25:234-241.
41. Kunkel HG. Estimation of alterations of serum gamma globulin by a turbidometric technique. Proc Soc Exp Biol 1947;66:217-224.
42. Joske RA, King WE. The LE cell phenomenon in active chronic viral hepatitis. Lancet 1955;2:477-480.
43. Leoni A. A proposito della specificità del fenomeno LE. Minerva Med 1954;1:1022-1027.
44. Hargraves MM. Discovery of the LE cell and its morphology. Mayo Clin Proc 1969;44:579-599.
45. Hargraves MM, Richmond H, Morton R. Presentation of two bone marrow elements: The "Tart" cell and the "L.E." cell. Proc Staff Meet Mayo Clinic 1948;23:25-28.
46. Mackay IR, Taft LI, Cowling DC. Lupoid hepatitis. Lancet 1956;2:1323-1326.
47. Mackay IR, Taft LI, Cowling DC. Lupoid hepatitis and the hepatic lesions of systemic lupus erythematosis. Lancet 1959:1;65-69.
48. Reynolds TB, Edmondson HA, Peters RL, Redeker A. Lupoid hepatitis. Ann Int Med 1964;61:650-666.
49. Runyon BA, LaBrecque DR, Anuras S. The spectrum of liver disease in systemic lupus erythematosus. Report of 343 histologically-proved cases and review of the literature. Am J Med 1980;69:187-194.
50. Mackay IR, Whittingham S. "Auto-Immune" chronic hepatitis. In: Foulk WT, ed. Diseases of the Liver. Postgraduate Medicine Series. New York: McGraw-Hill Book Co., 1968;74-86.
51. Soloway RD, Summerskill WHJ, Bagenstoss AH, Schoenfield LJ. "Lupoid" hepatitis, a nonentity in the spectrum of chronic active liver disease. Gastroenterology 1972;63:458-465.
52. Holborow EJ, Asherson GL, Johnson GD, Barnes RDS, Carmichael DS. Antinuclear factor and other antibodies in blood and liver disease. Br Med J 1963;1:656-658.
53. Desmnet VJ. Histological classification of chronic hepatitis. Acta Gastroenterologica Belgica 1997;60:259-267.
54. Mackay IR. The hepatitis-lupus connection. Semin Liver Dis 1991;11:234-240.
55. Mackay IR. Hepatic disease and systemic lupus erythematosus: coincidence or convergence. In: Lahita RG, ed. Systemic Lupus Erythematosus. 4th Edition. Chapter 35. Philadelphia: Elsevier Science 2003 (in press).
56. Johnson PJ, McFarlane IG. Meeting report: International Autoimmune Hepatitis Group. HEPATOLOGY 1993;18:998-1005.
57. International Autoimmune Hepatitis Group Report: Review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999;31:929-938.
58. Kamradt T, Mitchison NA. Tolerance and autoimmunity. N Engl J Med 2001;344:655-663.
59. Cohen IR. Kadishman's tree, Escher's angels, and the immunological homunculus. In: Continho A, Kazatchkine MD, eds. Autoimmunity: Physiology and Disease. New York: Wiley-Liss, 1994;7-18.
60. Nossal GJV. A purgative mastery. Nature 2001;412:685-686.
61. Silverstein AM, Rose NR. On the mystique of the immunological self. Immunol Rev 1997;159:197-206.
62. Rose NR, Mackay IR. Molecular mimicry: a critical look at exemplary issues in human diseases. Cell Mol Life Sci 2000;57:542-551.
63. Czaja CJ. Understanding the pathogenesis of autoimmune hepatitis. Am J Gastroenterol 2001;96:1224-1231.
64. Kita H, Mackay IR, Van de Water J, Gershwin ME. The lymphoid liver: considerations on pathways to autoimmune injury. Gastroenterology 2001;120:1485-1501.
65. Vergani D, Mieli-Vergani G. Autoimmunity after liver transplantation. HEPATOLOGY 2002;36:271-276.
66. Ehrlich P, Morgenroth J. Über Hämolysine: fünfte Mitteilung. Berlin klin Włochenschr 1901;38:251-258.
67. Mackay IR. Autoimmunity: paradigms of Burnet and complexities of today. Immunol Cell Biol 1992;70:159-171.
68. Albert LJ, Inman RD. Molecular mimicry and autoimmunity. N Engl J Med 1999;341:2068-2674.
69. Czaja AJ. Treatment strategies in autoimmune hepatitis. Clin Liver Dis 2002;6:799-824.